Rheuminate is a monthly selection of new publications clinically relevant to the SMART community of Canadian rheumatologists.
In this second issue, we consider the following topics:
- Glucocorticoid use in the Canadian Early Arthritis Cohort
- Systematic review and network meta-analysis of CV and VTE risk with JAKi
- Comparative benefit-risk analysis of upadacitinib and adalimumab
>> Read Rheuminate Issue #2 here.
View all issues of Rheuminate online at smartrheum.org/rheuminate